# DCVC's Biotech Investments: 26 Startups in Its Portfolio (2026) > The 26 Biotech startups DCVC has backed, by stage: $3.2B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/data-collective-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series A 13 - [AbCellera](https://millionrounds.com/company/abcellera) - [Newleos Therapeutics](https://millionrounds.com/company/newleos-therapeutics) - [Samsara Eco](https://millionrounds.com/company/samsara-eco) - [Kanvas Biosciences](https://millionrounds.com/company/kanvas-biosciences) - [Solu Therapeutics](https://millionrounds.com/company/solu-therapeutics) - [Metabiota](https://millionrounds.com/company/metabiota) - [GenEdit](https://millionrounds.com/company/genedit) - [Transcriptic](https://millionrounds.com/company/transcriptic) - [Molecular Assemblies](https://millionrounds.com/company/molecular-assemblies) - [Capella BioScience](https://millionrounds.com/company/capella-bioscience) - [SyntaxBio](https://millionrounds.com/company/syntax-bio) - [Stemson Therapeutics](https://millionrounds.com/company/stemson-therapeutics) - [X-37](https://millionrounds.com/company/x-37) ## Series B 7 - [Sidewinder Therapeutics](https://millionrounds.com/company/sidewinder-therapeutics) - [Chroma Medicine](https://millionrounds.com/company/chroma-medicine) - [Lucira Health](https://millionrounds.com/company/lucira-health) - [Recursion](https://millionrounds.com/company/recursion) - [Enlitic](https://millionrounds.com/company/enlitic) - [Empirico](https://millionrounds.com/company/empirico) - [*3* 3Scan](https://millionrounds.com/company/3scan) ## Series C and later 4 - [Zymergen](https://millionrounds.com/company/zymergen) - [Ginkgo Bioworks](https://millionrounds.com/company/ginkgo-bioworks) - [Plexium](https://millionrounds.com/company/plexium) - [Frontier Medicines](https://millionrounds.com/company/frontier-medicines) ## Pre-seed and seed 2 - [*PB* Proxima Bio](https://millionrounds.com/company/proxima-bio) - [*MS* Molecular Stethoscope](https://millionrounds.com/company/molecular-stethoscope) ## Segment by segment ### Series A 13 startups · $959M raised - [**AbCellera**](https://millionrounds.com/company/abcellera) AbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes. Canada $526M - [**Newleos Therapeutics**](https://millionrounds.com/company/newleos-therapeutics) Newleos Therapeutics is a clinical-stage neuroscience and biotechnology company based in Boston, Massachusetts. United States $94M - [**Samsara Eco**](https://millionrounds.com/company/samsara-eco) Samsara Eco is an Australian biotechnology and environmental-tech company based in Sydney, specializing in enzymatic recycling technology. Australia $67M - [**Kanvas Biosciences**](https://millionrounds.com/company/kanvas-biosciences) Kanvas Biosciences is a biotechnology company based in Princeton, New Jersey, founded in 2020. United States $61M - [**Solu Therapeutics**](https://millionrounds.com/company/solu-therapeutics) Solu Therapeutics is a Boston-based clinical-stage biotechnology company focused on developing precision medicines to target and e United States $41M - [**Metabiota**](https://millionrounds.com/company/metabiota) Metabiota is a provider of field data and risk analytics solutions for organizations to mitigate infectious diseases. United States $35M - [**GenEdit**](https://millionrounds.com/company/genedit) GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery. United States $33M - [**Transcriptic**](https://millionrounds.com/company/transcriptic) Transcriptic is a robotic cloud laboratory for life science. United States $28M ### Series B 7 startups · $576M raised - [**Sidewinder Therapeutics**](https://millionrounds.com/company/sidewinder-therapeutics) Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases. United States $137M - [**Chroma Medicine**](https://millionrounds.com/company/chroma-medicine) Chroma Medicine, founded in 2021 and based in Boston/Cambridge, Massachusetts, is a biotechnology company focused on developing ep United States $135M - [**Lucira Health**](https://millionrounds.com/company/lucira-health) Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases. United States $95M - [**Recursion**](https://millionrounds.com/company/recursion) Recursion provides analytic data tool solutions such as recursion analyzers, mortgage company data and data cloud. United States $81M - [**Enlitic**](https://millionrounds.com/company/enlitic) Enlitic builds AI deep learning products to streamline radiologists' workflows and improve healthcare diagnosis. United States $62M - [**Empirico**](https://millionrounds.com/company/empirico) Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines. United States $45M - [*3* **3Scan**](https://millionrounds.com/company/3scan) United States $21M ### Series C and later 4 startups · $1.5B raised - [**Zymergen**](https://millionrounds.com/company/zymergen) United States $874M - [**Ginkgo Bioworks**](https://millionrounds.com/company/ginkgo-bioworks) Zymergen is now a part of Ginkgo Bioworks! United States $444M - [**Plexium**](https://millionrounds.com/company/plexium) Plexium is a biotechnology company based in San Diego, California, founded in 2018. United States $88M - [**Frontier Medicines**](https://millionrounds.com/company/frontier-medicines) Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines. United States $87M ### Pre-seed and seed 2 startups · $186M raised - [*PB* **Proxima Bio**](https://millionrounds.com/company/proxima-bio) United States $178M - [*MS* **Molecular Stethoscope**](https://millionrounds.com/company/molecular-stethoscope) United States $8.2M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names DCVC as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **DCVC's AI portfolio** 49 startups · $6.6B](https://millionrounds.com/portfolio-maps/data-collective-ai-portfolio)[Sector portfolio **DCVC's Big Data & Analytics portfolio** 26 startups · $1.7B](https://millionrounds.com/portfolio-maps/data-collective-big-data-analytics-portfolio)[Sector portfolio **DCVC's IT Services portfolio** 12 startups · $460M](https://millionrounds.com/portfolio-maps/data-collective-it-services-portfolio)[Co-investors **Who invests with DCVC** 334 co-investors](https://millionrounds.com/portfolio-maps/data-collective-co-investors)[Portfolio map **DCVC portfolio map** 181 startups · $21B](https://millionrounds.com/portfolio-maps/data-collective-portfolio-map)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio) ## Raising from investors like DCVC? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)